跳到正文

INAB — In8Bio Inc 机构持仓 · 2026年Q3

谁持有 In8Bio Inc(INAB)?2026年Q3(报告期截至 2026-09-30)共有 22 家机构在 SEC 13F 申报中报告持有,合计 457.30 万美元。前几大持有机构:Alyeska Investment Group, L.P.(130.00 万美元)、683 Capital Management, LLC(96.38 万美元)、Stonepine Capital Management, LLC(92.81 万美元)。

排名机构市值股数变动
1Alyeska Investment Group, L.P.130万美元94.43万持平
2683 Capital Management, LLC96.38万美元72.46万持平
3Stonepine Capital Management, LLC92.81万美元69.79万增持
4FRANKLIN RESOURCES INC85.12万美元91.45万持平
5VANGUARD GROUP INC17.61万美元13.24万持平
6BIOS Capital Management, LP10.77万美元8.1万持平
7GEODE CAPITAL MANAGEMENT, LLC8.37万美元6.3万减持
8UBS Group AG4.91万美元3.7万增持
9RENAISSANCE TECHNOLOGIES LLC4.51万美元3.39万增持
10Texas Capital Bank Wealth Management Services Inc3.13万美元2.35万减持
11CITADEL ADVISORS LLC3.06万美元2.3万减持
12NORTHERN TRUST CORP2.89万美元2.17万持平
13Squarepoint Ops LLC1.44万美元1.08万新建仓
14NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO3,704美元2,785持平
15Tower Research Capital LLC (TRC)2,012美元1,513减持
16JONES FINANCIAL COMPANIES LLLP922美元768持平
17SBI Securities Co., Ltd.133美元100新建仓
18BlackRock, Inc.112美元84持平
19Rockefeller Capital Management L.P.110美元83持平
20BARCLAYS PLC3美元2减持
21CAPTRUST FINANCIAL ADVISORS0美元0清仓
22OPPENHEIMER & CO INC0美元0清仓

来源:SEC 13F 申报文件 · 截至 2026-09-30